⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13678085 | 1.00 | — | — | |
| SCHEMBL11189303 | 0.78 | — | — | |
| SCHEMBL17198526 | 0.72 | — | — | |
| SCHEMBL142963 | 0.72 | — | — | |
| SCHEMBL8374487 | 0.72 | — | — | |
| SCHEMBL8584788 | 0.72 | — | — | |
| SCHEMBL1358035 | 0.72 | — | — | |
| SCHEMBL17864370 | 0.71 | — | — | |
| SCHEMBL16295693 | 0.67 | — | — | |
| Methylamine SCHEMBL9005257 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357307-A1 | CLEAVABLE CYCLIC LOOP NUCLEOTIDES FOR NANOPORE SEQUENCING | ILLUMINA, INC. | 2023-11-09 | — | — | US | claimed |
| WO-2023215506-A1 | CLEAVABLE CYCLIC LOOP NUCLEOTIDES FOR NANOPORE SEQUENCING | ILLUMINA, INC. (US) | 2023-11-09 | — | — | WO | claimed |
| WO-2023069927-A1 | METHODS FOR CAPTURING LIBRARY DNA FOR SEQUENCING | ILLUMINA, INC. (US) | 2023-04-27 | — | — | WO | claimed |
| WO-2021133770-A1 | NANOPARTICLE WITH SINGLE SITE FOR TEMPLATE POLYNUCLEOTIDE ATTACHMENT | ILLUMINA, INC. (US) | 2021-07-01 | — | — | WO | claimed |
| WO-2021133768-A1 | NANOPARTICLE WITH SINGLE SITE FOR TEMPLATE POLYNUCLEOTIDE ATTACHMENT | ILLUMINA, INC. (US) | 2021-07-01 | — | — | WO | claimed |
| EP-0507337-B1 | Novel erucyl, brassidyl and nervonyl derivatives | MAX PLANCK GESELLSCHAFT (DE) | 1996-10-23 | — | — | EP | claimed |
| US-20260091365-A1 | NANOPARTICLE WITH SINGLE SITE FOR TEMPLATE POLYNUCLEOTIDE ATTACHMENT | ILLUMINA, INC. (US) | 2026-04-02 | — | — | US | disclosed |
| EP-4373958-A1 | METHODS FOR PREPARING SUBSTRATE SURFACE FOR DNA SEQUENCING | ILLUMINA, INC. (US) | 2024-05-29 | — | — | EP | disclosed |
| US-20240124916-A1 | NANOPARTICLE WITH POLYNUCLEOTIDE BINDING SITE AND METHOD OF MAKING THEREOF | ILLUMINA CAMBRIDGE LIMITED (GB) | 2024-04-18 | — | — | US | disclosed |
| WO-2024057280-A1 | NANOPARTICLE WITH POLYNUCLEOTIDE BINDING SITE AND METHOD OF MAKING THEREOF | ILLUMINA CAMBRIDGE LIMITED (GB) | 2024-03-21 | — | — | WO | disclosed |
| US-20230381718-A1 | BARRIERS INCLUDING MOLECULES COVALENTLY BONDED TO AMPHIPHILIC MOLECULES, AND METHODS OF MAKING THE SAME | ILLUMINA CAMBRIDGE LIMITED (GB) | 2023-11-30 | — | — | US | disclosed |
| WO-2023215506-A1 | CLEAVABLE CYCLIC LOOP NUCLEOTIDES FOR NANOPORE SEQUENCING | ILLUMINA, INC. (US) | 2023-11-09 | — | — | WO | disclosed |
| US-20230357307-A1 | CLEAVABLE CYCLIC LOOP NUCLEOTIDES FOR NANOPORE SEQUENCING | ILLUMINA, INC. | 2023-11-09 | — | — | US | disclosed |
| WO-2021133768-A1 | NANOPARTICLE WITH SINGLE SITE FOR TEMPLATE POLYNUCLEOTIDE ATTACHMENT | ILLUMINA, INC. (US) | 2021-07-01 | — | — | WO | disclosed |
| US-20210187470-A1 | NANOPARTICLE WITH SINGLE SITE FOR TEMPLATE POLYNUCLEOTIDE ATTACHMENT | llumina, Inc. (US) | 2021-06-24 | — | — | US | disclosed |
| US-20210187469-A1 | NANOPARTICLE WITH SINGLE SITE FOR TEMPLATE POLYNUCLEOTIDE ATTACHMENT | ILLUMINA, INC. (US) | 2021-06-24 | — | — | US | disclosed |
| EP-3640332-A1 | OLIGOMER-CONJUGATE COMPLEXES AND THEIR USE | Ionis Pharmaceuticals, Inc. (US) | 2020-04-22 | — | — | EP | disclosed |
| EP-3453761-A1 | OLIGOMER-CONJUGATE COMPLEXES AND THEIR USE | Ionis Pharmaceuticals, Inc. (US) | 2019-03-13 | — | — | EP | disclosed |
| US-20050112661-A1 | Methods for delivering nucleic acid molecules into cells and assessment thereof | GLAXO GROUP LIMITED (GB) | 2005-05-26 | — | — | US | disclosed |
| US-20040265996-A1 | Method for the preparation of isolated cell cultures, culture meidum for the cultivation of cell cultures, and cell cultures | NEUROPROGEN GMBH LEIPZIG (DE) | 2004-12-30 | — | — | US | disclosed |